Tag: ALES Global Japan and Beyond Next Ventures
Biologics to garner $120 billion worth sales revenue by 2027, predicts...
Biologics are poised to emerge as dominating molecule type in solid tumor indication, overtaking innovative small molecules in terms of sales revenue, according to GlobalData
MediBuddy raised $40 Million in Series B funding in February 2021
The Series B funding was led by the recent investment of $20 Million by Indian Life Sciences Fund III, LLC and with participation from other investors....................